TRAZIMERA
Powder for concentrate for solution for infusion, 150mg
RxActive license
Active substance (INN)
trastuzumab
Pharmaceutical form
Pharmaceutical formPowder for concentrate for solution for infusion
Strength150mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerPfizer Manufacturing Belgium NV, Belgium
Therapeutic groupAntineoplastic and immunomodulating agents (L01FD01)
Marketing authorization holder"EVROPA LEK PHARMA" DOO PODGORICA
Authorization dateNovember 5, 2021
Analogs in Montenegro
2Other medicines with the same active substance
Source: CInMED register